ArticleTherapeutic advances in hematology2026
The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia.
Zixuan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.